What is the difference between GHRP-6 and Sermorelin?

GHRP-6: GHRP-6 is a first-generation synthetic hexapeptide GH secretagogue that strongly stimulates pituitary GH release via ghrelin receptor activation. It is one of the oldest and most well-studied GHRPs, with a large body of research spanning more than three decades. GHRP-6 produces significant GH pulses but is notable for powerfully stimulating appetite — a side effect that can be beneficial for those in a caloric deficit or disadvantageous for those managing body composition. Sermorelin: Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take GHRP-6 and Sermorelin together?

There is no specific, well-documented interaction rule for combining GHRP-6 and Sermorelin in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, GHRP-6 or Sermorelin?

GHRP-6 is currently preclinical only and Sermorelin is fda-approved. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

GHRP-6 vs Sermorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

GHRP-6

Preclinical only

GHRP-6 is a first-generation synthetic hexapeptide GH secretagogue that strongly stimulates pituitary GH release via ghrelin receptor activation. It is one of the oldest and most well-studied GHRPs, with a large body of research spanning more than three decades. GHRP-6 produces significant GH pulses but is notable for powerfully stimulating appetite — a side effect that can be beneficial for those in a caloric deficit or disadvantageous for those managing body composition.

Full profile

Sermorelin

FDA-approved

Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.

Full profile

	GHRP-6	Sermorelin
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	Growth Hormone Releasing Peptide-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2	GHRH 1-29, GRF 1-29 NH2, Geref
Evidence	Preclinical only	FDA-approved
Dosing range	100mcg–300mcg mcg, 1–3 times daily, on an empty stomach	100mcg–500mcg mcg, once daily (before sleep)
Administration	Subcutaneous injection, Intramuscular injection	Subcutaneous injection
Key side effects	Strong increase in appetite (most common and notable), Elevated cortisol and prolactin at higher doses, Water retention / bloating, Fatigue at high doses	Injection site redness, Headache, Flushing, Dizziness
Cited sources	3 references	1 reference

Key differences

Evidence level differs: GHRP-6 is preclinical only, while Sermorelin is fda-approved.
Administration: GHRP-6 — Subcutaneous injection, Intramuscular injection; Sermorelin — Subcutaneous injection.
Frequency: GHRP-6 is typically 1–3 times daily, on an empty stomach; Sermorelin is once daily (before sleep).
Research depth: this profile cites 3 sources for GHRP-6 vs 1 for Sermorelin.

How each works

GHRP-6

Human studies confirm GHRP-6 robustly elevates GH within 15–30 minutes of injection, with effects diminishing toward baseline within 2–3 hours. Chronic use increases baseline IGF-1. Research also indicates mild stimulation of cortisol and prolactin, particularly at higher doses. Animal models have shown potential cardioprotective, hepatoprotective, and muscle-sparing effects, though human equivalents are not established.

Sermorelin

Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.

Read the full GHRP-6 profile Read the full Sermorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.